Moderna, Inc. — Director's Dealing 2020

Jul 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-07-20

Reporting Person: Zaks Tal Zvi (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-20	Common Stock	M	10000	$20.93	Acquired	10000	Direct
2020-07-20	Common Stock	M	10000	$19.15	Acquired	20000	Direct
2020-07-20	Common Stock	S	400	$78.77	Disposed	19600	Direct
2020-07-20	Common Stock	S	1650	$80.49	Disposed	17950	Direct
2020-07-20	Common Stock	S	2205	$81.23	Disposed	15745	Direct
2020-07-20	Common Stock	S	4488	$82.49	Disposed	11257	Direct
2020-07-20	Common Stock	S	3425	$83.17	Disposed	7832	Direct
2020-07-20	Common Stock	S	2409	$84.53	Disposed	5423	Direct
2020-07-20	Common Stock	S	3469	$85.58	Disposed	1954	Direct
2020-07-20	Common Stock	S	1000	$86.37	Disposed	954	Direct
2020-07-20	Common Stock	S	354	$87.41	Disposed	600	Direct
2020-07-20	Common Stock	S	400	$88.76	Disposed	200	Direct
2020-07-20	Common Stock	S	200	$90.64	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-20	Stock Option (Right to Buy)	$20.93	M	10000	Disposed	2029-03-08	Common Stock (10000)	Direct
2020-07-20	Stock Option (Right to Buy)	$19.15	M	10000	Disposed	2026-08-10	Common Stock (10000)	Direct

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.41 to $79.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.77 to $80.76 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.80 to $81.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.81 to $82.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.82 to $83.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.96 to $84.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.97 to $85.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.98 to $86.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.05 to $87.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.59 to $88.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F12: This option is fully vested and exercisable.

F13: This option is fully vested and exercisable.